Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05481476
What this trial is testing

Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sun Yat-sen University 32
Early research (Phase 1)Not Yet RecruitingNCT07707674
What this trial is testing

Phase I Open-Label Randomized Multicenter Study of XNW28012 Monotherapy in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Evopoint Biosciences Inc. 24
Not applicableStudy completedNCT02688218
What this trial is testing

Exercise Detection Study

Who this might be right for
Type 1 Diabetes
Oregon Health and Science University 30
Large-scale testing (Phase 3)Looking for participantsNCT07219238
What this trial is testing

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

Who this might be right for
Colorectal CancerGastric CancersOvarian Cancers+1 more
GE Healthcare 175
Not applicableApproved For MarketingNCT00786058
What this trial is testing

A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003

Who this might be right for
Pancreatic Cancer
CONKO-Studiengruppe
Early research (Phase 1)Study completedNCT01571817
What this trial is testing

Pancreatic Islet Transplantation Into the Gastric Submucosa

Who this might be right for
Type 1 Diabetes
Andrew Posselt 1
Not applicableLooking for participantsNCT06287749
What this trial is testing

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

Who this might be right for
Pancreatic Cancer ResectablePancreatic Ductal AdenocarcinomaMinimal Residual Disease+2 more
University Hospital, Montpellier 37
Not applicableNot Yet RecruitingNCT07839676
What this trial is testing

A Prospective Study of Concurrent Hyperthermia, Chemotherapy and Radiotherapy in Borderline and Locally Advanced Pancreatic Cancer (PANHEAT)

Who this might be right for
Borderline and Locally Advanced Pancreatic Cancer
Fernando Pessoa Canarias University 60
Not applicableLooking for participantsNCT05474417
What this trial is testing

The Effects of the CF Carrier State on the Kidneys and Pancreas

Who this might be right for
Carrier StatePancreatic DiseaseKidney Diseases
Philip Polgreen 1,250
Testing effectiveness (Phase 2)Study completedNCT01983774
What this trial is testing

Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations

Who this might be right for
Cystic Fibrosis
Columbia University 21
Testing effectiveness (Phase 2)Ended earlyNCT05101915
What this trial is testing

Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus

Who this might be right for
Cystic Fibrosis
Papworth Hospital NHS Foundation Trust 6
Not applicableStudy completedNCT01807325
What this trial is testing

RNA Sequencing of Solid and Cystic Lesions of the Pancreas

Who this might be right for
Pancreas CystPancreas Mass
Oregon Health and Science University 72
Not applicableStudy completedNCT01465711
What this trial is testing

The Value of PSP in Predicting Outcome in ICU Surgical Peritonitis Patients

Who this might be right for
PeritonitisSepsisMultiple Organ Failure+1 more
University of Magdeburg 137
Testing effectiveness (Phase 2)Study completedNCT02403271
What this trial is testing

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerBreast CancerPancreatic Cancer
Pharmacyclics LLC. 124
Testing effectiveness (Phase 2)Study completedNCT00005926
What this trial is testing

Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas

Who this might be right for
Pancreatic CancerPancreatic Neoplasm
National Cancer Institute (NCI) 50
Not applicableLooking for participantsNCT03161808
What this trial is testing

Rare CFTR Mutation Cell Collection Protocol (RARE)

Who this might be right for
Cystic Fibrosis
George Solomon 500
Testing effectiveness (Phase 2)Ended earlyNCT06630325
What this trial is testing

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Who this might be right for
Advanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more
OHSU Knight Cancer Institute 6
Not applicableStudy completedNCT06118125
What this trial is testing

Delay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic Confinement

Who this might be right for
Neoplasms, ColorectalGeneral PractitionerPandemic, COVID-19+4 more
University of Bordeaux 376
Not applicableUnknownNCT02550847
What this trial is testing

Evaluation of Prognosis With Integrated MRI/PET in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Taiwan University Hospital 100
Early research (Phase 1)Study completedNCT01944735
What this trial is testing

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Celtaxsys, Inc. 17
Next Page